S
Stephan Störkel
Researcher at Witten/Herdecke University
Publications - 87
Citations - 5355
Stephan Störkel is an academic researcher from Witten/Herdecke University. The author has contributed to research in topics: Cancer & Renal cell carcinoma. The author has an hindex of 31, co-authored 85 publications receiving 5122 citations. Previous affiliations of Stephan Störkel include University of Mainz & University of Münster.
Papers
More filters
Journal ArticleDOI
The Heidelberg classification of renal cell tumours
Gyula Kovacs,Mohammed Akhtar,Bruce Beckwith,Peter Bugert,Colin Cooper,Brett Delahunt,John N. Eble,Stewart Fleming,Börje Ljungberg,L. Jeffrey Medeiros,Holger Moch,Victor E. Reuter,Eberhard Ritz,Göran Roos,Dietmar Schmidt,John R. Srigley,Stephan Störkel,Eva van den Berg,Bert Zbar +18 more
TL;DR: This paper presents the conclusions of a workshop entitled ‘Impact of Molecular Genetics on the Classification of Renal Cell Tumours’, which was held in Heidelberg in October 1996 and is applicable to routine diagnostic practice.
Journal ArticleDOI
Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95
Thomas Wiegel,Dirk Bottke,Ursula Steiner,Alessandra Siegmann,Reinhard Golz,Stephan Störkel,Norman Willich,Axel Semjonow,Rainer Souchon,Michael Stöckle,Christian Rübe,Lothar Weissbach,Peter Althaus,Udo Rebmann,T. Kälble,Horst Jürgen Feldmann,Manfred P. Wirth,Axel Hinke,Wolfgang Hinkelbein,Kurt Miller +19 more
TL;DR: Adjuvant RT for pT3 prostate cancer with postoperatively undetectable PSA significantly reduces the risk of biochemical progression and further follow-up is needed to assess the effect on metastases-free and overall survival.
Journal ArticleDOI
Immunohistochemical Detection of EGFR in Paraffin-embedded Tumor Tissues: Variation in Staining Intensity Due to Choice of Fixative and Storage Time of Tissue Sections
Derek Atkins,Karl-August Reiffen,Conny Lund Tegtmeier,Henrik Winther,Marcellus Stephanus Bonato,Stephan Störkel +5 more
TL;DR: Depending on the fixative used and the time of storage of cut tissue sections, a variation in the determined level of EGFR expression was demonstrated compared with the most optimal fixation procedure.
Journal Article
VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.
Hiltrud Brauch,Gregor Weirich,Jürgen Brieger,Damjan Glavač,Heinz Rödl,Mariola Eichinger,Matthias Feurer,Eberhardt Weidt,Chutintorn Puranakanitstha,Christine Neuhaus,Sigmund Pomer,Walburgis Brenner,Peter Schirmacher,Stephan Störkel,Michael Rotter,Andrej Mašera,Nadja Gugeler,Hans-Joachim Decker +17 more
TL;DR: This is the first evidence of frequent somatic VHL mutations at a particular site within exon 2 and an association of V HL mutations/hypermethylations with a standard prognostic factor.
Journal ArticleDOI
Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study
Lisa Licitra,Ricard Mesia,Fernando Rivera,Éva Remenár,Ricardo Hitt,Jozsef Erfan,Sylvie Rottey,Andrzej Kawecki,D. Zabolotnyy,Marco Benasso,Stephan Störkel,Stefanie Senger,C. Stroh,Jan B. Vermorken +13 more
TL;DR: Tumor EGFR copy number is not a predictive biomarker for the efficacy of cetuximab plus platinum/5-FU as first-line therapy for patients with R/M SCCHN.